{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:25:45Z","timestamp":1792506345557,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatic metastases from epithelial ovarian cancer (EOC) represent an advanced disease stage, yet national guidelines provide no standardized recommendations for liver resection. This study aimed to describe the national trends and patterns of hepatic resections in EOC patients based on German hospital billing data (DRG system) from 2020 to 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective epidemiological analysis was conducted using InEK (Institute for Hospital Remuneration Systems) datasets from 2020 to 2024. We extracted data related to diagnosis ICD code C56 (malignant neoplasm of the ovary) and OPS codes for hepatic resections (5-501.0, 5-502.0, 5-502.2, 5-502.3, 5-502.4, 5-502.5, 5-502.6). Case numbers, procedure frequency, hospital characteristics, and DRG classifications were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1,273 hepatic resections were performed in patients with ovarian cancer between 2020 and 2024. Annual case numbers ranged from 225 to 283, indicating stable surgical practice over time. Local excisions \/ atypical resections accounted for the majority (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091,165; 91%), while segmentectomies (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200985; 6.7%) and major resections (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923; 1.8%) were less frequent but consistently performed. Age group analysis showed that the largest proportion of patients undergoing hepatic resection were aged 65\u201374 years (range 23%\u201327% yearly). followed by the 60\u201364 and 55\u201359 age groups. Younger patients (&lt;\u200940 years) represented less than 5%. Most procedures (54.6%) were conducted in public hospitals with \u2265\u20091000 beds, with additional contributions from private non-profit (20.9%) and private for-profit (10.5%) institutions. A gradual increase in the share of private institutions was observed over time. The mean hospital stay varied by resection type: 16.7 days for local excisions, 17.1 days for segmentectomies, and 20.1 days for major resections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hepatic resection for ovarian cancer is performed regularly in Germany, primarily at high-volume centers, suggesting a growing clinical acceptance of aggressive cytoreduction strategies despite the absence of formal recommendations. Our findings underline the need for prospective, multicenter studies and guideline updates addressing hepatic metastases in ovarian cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-025-04064-x","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:46:04Z","timestamp":1760964364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatic resection for ovarian cancer in Germany: a nationwide epidemiological study based on DRG (diagnosis-related groups) data (2020\u20132024)"],"prefix":"10.1186","volume":"23","author":[{"given":"Miklos","family":"Acs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gebhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt J.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Bogovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hofmarksrichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"4064_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4064_CR2","unstructured":"Gesellschaft der epidemiologischen. Krebsregister in Deutschland e.V. (GEKID) & Zentrum f\u00fcr Krebsregisterdaten (ZfKD) im Robert Koch-Institut. (2023). Krebs in Deutschland f\u00fcr 2019\/2020 (14. Ausgabe). 2023."},{"key":"4064_CR3","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"4064_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10585-019-10007-0","volume":"37","author":"AB Gardner","year":"2020","unstructured":"Gardner AB, Charo LM, Mann AK, Kapp DS, Eskander RN, Chan JK. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes. Clin Exp Metastasis. 2020;37:107\u201313.","journal-title":"Clin Exp Metastasis"},{"key":"4064_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.21037\/hbsn.2018.12.06","volume":"8","author":"M Wang","year":"2019","unstructured":"Wang M, Zhou J, Zhang L, Zhao Y, Zhang N, Wang L, Zhu W, He X, Zhu H, Xu W, et al. Surgical treatment of ovarian cancer liver metastasis. Hepatobiliary Surg Nutr. 2019;8:129\u201337.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"4064_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1245\/s10434-006-9185-7","volume":"14","author":"J Esquivel","year":"2007","unstructured":"Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D, Bartlett D, Barone R, Barrios P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of surgical oncology. Ann Surg Oncol. 2007;14:128\u201333.","journal-title":"Ann Surg Oncol"},{"key":"4064_CR7","unstructured":"Deutsche Krebsgesellschaft DK, AWMF. : S3-Leitlinie Kolorektales Karzinom AWMF-Registernummer: 021-007OL. 2025."},{"key":"4064_CR8","unstructured":"Deutsche Krebsgesellschaft DKA. S3-Leitlinie Diagnostik,Therapie und Nachsorge maligner Ovarialtumoren AWMF-Registernummer: 032-035OL. 2024."},{"key":"4064_CR9","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1097\/IGC.0000000000001041","volume":"27","author":"D Querleu","year":"2017","unstructured":"Querleu D, Planchamp F, Chiva L, Fotopoulou C, Barton D, Cibula D, Aletti G, Carinelli S, Creutzberg C, Davidson B, et al. European society of gynaecological oncology (ESGO) guidelines for ovarian cancer surgery. Int J Gynecol Cancer. 2017;27:1534\u201342.","journal-title":"Int J Gynecol Cancer"},{"key":"4064_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12957-015-0652-0","volume":"13","author":"N Bacalbasa","year":"2015","unstructured":"Bacalbasa N, Dima S, Brasoveanu V, David L, Balescu I, Purnichescu-Purtan R, Popescu I. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and May bring survival benefit. World J Surg Oncol. 2015;13:235.","journal-title":"World J Surg Oncol"},{"key":"4064_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.21873\/anticanres.16864","volume":"44","author":"M Acs","year":"2024","unstructured":"Acs M, Herold Z, Neumann LEA, Slowik P, Evert K, Gurok S, Panczel I, Barna AJ, Dank M, Szasz AM, et al. Surgical treatment and outcome of ovarian cancer patients with liver metastases: experience of a tertiary hepatic and peritoneal surface malignancy center. Anticancer Res. 2024;44:731\u201341.","journal-title":"Anticancer Res"},{"key":"4064_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ygyno.2008.09.046","volume":"112","author":"MC Lim","year":"2009","unstructured":"Lim MC, Kang S, Lee KS, Han SS, Park SJ, Seo SS, Park SY. The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer. Gynecol Oncol. 2009;112:28\u201334.","journal-title":"Gynecol Oncol"},{"key":"4064_CR13","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00432-015-2090-3","volume":"142","author":"ML Gasparri","year":"2016","unstructured":"Gasparri ML, Grandi G, Bolla D, Gloor B, Imboden S, Panici PB, Mueller MD, Papadia A. Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer. J Cancer Res Clin Oncol. 2016;142:1509\u201320.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4064_CR14","doi-asserted-by":"publisher","first-page":"571671","DOI":"10.3389\/fonc.2020.571671","volume":"10","author":"H Zhao","year":"2020","unstructured":"Zhao H, Xu F, Li J, Ni M, Wu X. A Population-Based study on liver metastases in women with newly diagnosed ovarian cancer. Front Oncol. 2020;10:571671.","journal-title":"Front Oncol"},{"key":"4064_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2214\/AJR.05.0004","volume":"187","author":"JW Kwek","year":"2006","unstructured":"Kwek JW, Iyer RB. Recurrent ovarian cancer: spectrum of imaging findings. AJR Am J Roentgenol. 2006;187:99\u2013104.","journal-title":"AJR Am J Roentgenol"},{"key":"4064_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ygyno.2015.12.007","volume":"140","author":"B Ataseven","year":"2016","unstructured":"Ataseven B, Grimm C, Harter P, Heitz F, Traut A, Prader S, du Bois A. Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV. Gynecol Oncol. 2016;140:215\u201320.","journal-title":"Gynecol Oncol"},{"key":"4064_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ygyno.2016.06.013","volume":"142","author":"B Ataseven","year":"2016","unstructured":"Ataseven B, Chiva LM, Harter P, Gonzalez-Martin A, du Bois A. FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited. Gynecol Oncol. 2016;142:597\u2013607.","journal-title":"Gynecol Oncol"},{"key":"4064_CR18","doi-asserted-by":"publisher","first-page":"e0299504","DOI":"10.1371\/journal.pone.0299504","volume":"19","author":"N Li","year":"2024","unstructured":"Li N, Jin S, Wu J, Ji H, Du C, Liu B. Effect of different treatment modalities on ovarian cancer patients with liver metastases: A retrospective cohort study based on SEER. PLoS ONE. 2024;19:e0299504.","journal-title":"PLoS ONE"},{"key":"4064_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/gyn.2019.0074","volume":"36","author":"J Luna-Abanto","year":"2020","unstructured":"Luna-Abanto J, Garcia Ruiz L, Laura Martinez J, Alvarez Larraondo M, Villoslada Terrones V. Liver resection as part of cytoreductive surgery for ovarian cancer. J Gynecol Surg. 2020;36:70\u20135.","journal-title":"J Gynecol Surg"},{"key":"4064_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/541842","volume":"2012","author":"E Halkia","year":"2012","unstructured":"Halkia E, Spiliotis J, Sugarbaker P. Diagnosis and management of peritoneal metastases from ovarian cancer. Gastroenterol Res Pract. 2012;2012:1\u201312.","journal-title":"Gastroenterol Res Pract"},{"key":"4064_CR21","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1097\/IGC.0b013e31829dc923","volume":"23","author":"E Ch\u00e9reau","year":"2013","unstructured":"Ch\u00e9reau E, Lambaudie E, Houvenaeghel G. Morbidity of surgery after neoadjuvant chemotherapy including bevacizumab for advanced ovarian cancer. Int J Gynecol Cancer. 2013;23:1326\u201330.","journal-title":"Int J Gynecol Cancer"},{"key":"4064_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.31083\/j.ejgo4301015","volume":"43","author":"S Forte","year":"2022","unstructured":"Forte S, Ferrari F, Valenti G, Capozzi VA, Santana BN, Babin G, Guyon F. Liver surgery for advanced ovarian cancer: a systematic review of literature. Eur J Gynaecol Oncol. 2022;43:64.","journal-title":"Eur J Gynaecol Oncol"},{"key":"4064_CR23","doi-asserted-by":"crossref","unstructured":"Wu C-X, Chen M-L, Zhang H, Han J-J. Percutaneous radiofrequency ablation combined with chemotherapy versus chemotherapy only for ovarian cancer liver metastasis. Front Oncol. 2022; 11.","DOI":"10.3389\/fonc.2021.793024"},{"key":"4064_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/IGC.0000000000000026","volume":"24","author":"V Kolev","year":"2014","unstructured":"Kolev V, Pereira EB, Schwartz M, Sarpel U, Roayaie S, Labow D, Momeni M, Chuang L, Dottino P, Rahaman J, Zakashansky K. The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. Int J Gynecol Cancer. 2014;24:70\u20134.","journal-title":"Int J Gynecol Cancer"},{"key":"4064_CR25","unstructured":"NCCN Guidelines colon cancer Version1.2022. pp. National Comprehensive Cancer Network (NCCN); 2022."},{"key":"4064_CR26","doi-asserted-by":"crossref","unstructured":"Gallotta V, Conte C, D\u2019Indinosante M, Capoluongo E, Minucci A, De Rose AM, Ardito F, Giuliante F, Di Giorgio A, Zannoni GF, Fagotti A, Margreiter C, Scambia G, Ferrandina G. Prognostic factors value of germline and somatic Brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases. Eur J Surg Oncol. 2019;2096\u2013102.","DOI":"10.1016\/j.ejso.2019.06.023"},{"key":"4064_CR27","doi-asserted-by":"crossref","unstructured":"Oliva R, De Rose AM, Ardito F, Guidi G, Certelli C, Bruno M, Fagotti A, Gallotta V. Three-dimensional reconstruction and laparoscopic liver resection for recurrent ovarian cancer: quaternary cytoreductive surgery. Int J Gynecol Cancer. 2025:101914.","DOI":"10.1016\/j.ijgc.2025.101914"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04064-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:46:12Z","timestamp":1760964372000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04064-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4064"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04064-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable Patient data were retrieved from the Institute for the Hospital Remuneration System (InEK). These data represent nationwide German DRG case data and are freely accessible for medical research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}